A Placebo-Controlled Study of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor Administered During and After Induction Treatment for De Novo Acute Myelogenous Leukemia in Elderly Patients

Idarubicin Induction chemotherapy
DOI: 10.1182/blood.v91.8.2722.2722_2722_2730 Publication Date: 1998-04-15